The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine - PubMed (original) (raw)
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
Paolo Bianco et al. Nat Med. 2013 Jan.
Abstract
Mesenchymal stem cells (MSCs) are the focus of intensive efforts worldwide directed not only at elucidating their nature and unique properties but also developing cell-based therapies for a diverse range of diseases. More than three decades have passed since the original formulation of the concept, revolutionary at the time, that multiple connective tissues could emanate from a common progenitor or stem cell retained in the postnatal bone marrow. Despite the many important advances made since that time, substantial ambiguities still plague the field regarding the nature, identity, function, mode of isolation and experimental handling of MSCs. These uncertainties have a major impact on their envisioned therapeutic use.
Figures
Figure 1. The whereabouts of MSCs
In the postnatal BM, ‘MSCs’ reside around sinusoids, maintain a ‘niche’ for HSCs, support hematopoiesis, and replenish the differentiated compartment of osteoblasts and adipocytes during tissue growth and turnover; they also generate cartilage under specific conditions such as trauma). Total populations of bone marrow stromal cells (which do not coincide with cultures of ‘stem cells’ in any way) are established when total marrow cell suspensions are plated in culture at high density. Adherence to plastic separates the stromal cells from no-adherent hematopoietic cells. If cell suspensions are plated a low density, only cells capable of density-insensitive growth are selected. These cells initiate the growth of clonal colonies. Passaging a single colony, or alternatively, establishing a clonal culture from single cells isolated based on expression of phenotypic markers (which may be different in humans and mouse), results in a clonal population, which can be used to assess multipotency by in vivo transplantation. Heterotopic ossicles include multiple differentiated cell types of donor origin (osteoblasts, adipocytes, fibroblasts) and hematopoietic cells of the host. These are supported by donor stromal cells. X-ray and histology images show a heterotopic ossicle made by murine MSCs transplanted on a completely resorbable scaffold (GelfoamTM).
Figure 2. How MSCs make it to bone marrow
In development, the primitive bone marrow stroma include skeletal progenitors that originate outside of the marrow cavity (primitive periosteum-perichondrium) and invade the forming cavity along blood vessels. Similar dynamic interactions with ingrowing blood vessels are reproduced in transplants of human MSCs, and are likely the basis for the perisinusoidal position of MSCs in the intact postnatal bone marrow. Recruitment of mesenchymal cells to a mural cell fate (and a subendothelial position), a general phenomenon in development and organ growth, is mediated by endothelial cell-derived PDGF-BB, which signals through PDGF-Rβ expressed on mesenchymal cells (and on ‘MSCs’). Presumptive mural cells produce Angiopoietin-1, (also produced by human and murine bone marrow MSCs2), which is crucial for integrity, survival and remodeling of vascular lattices. Ang-1 also induces quiescence of HSCs. Both mural cells and endothelial cell are induced to mitotic quiescence by active TGF 1, which is released through proteolytic cleavage of the latent form at sites of mural cell-endothelial cell contacts (reviewed in , , –40).
Comment in
- MSCs: science and trials.
Pittenger MF. Pittenger MF. Nat Med. 2013 Jul;19(7):811. doi: 10.1038/nm.3219. Nat Med. 2013. PMID: 23836215 No abstract available. - MSCs: science and trials.
Phinney DG, Galipeau J, Krampera M, Martin I, Shi Y, Sensebe L. Phinney DG, et al. Nat Med. 2013 Jul;19(7):812. doi: 10.1038/nm.3220. Nat Med. 2013. PMID: 23836216 No abstract available. - MSCs: science and trials.
Fibbe WE, Dazzi F, LeBlanc K. Fibbe WE, et al. Nat Med. 2013 Jul;19(7):812-3. doi: 10.1038/nm.3222. Nat Med. 2013. PMID: 23836217 No abstract available. - Reply to MSCs: science and trials.
Bianco P. Bianco P. Nat Med. 2013 Jul;19(7):813-4. doi: 10.1038/nm.3255. Nat Med. 2013. PMID: 23836218 No abstract available.
Similar articles
- Muscle Stem/Progenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies.
Klimczak A, Kozlowska U, Kurpisz M. Klimczak A, et al. Arch Immunol Ther Exp (Warsz). 2018 Oct;66(5):341-354. doi: 10.1007/s00005-018-0509-7. Epub 2018 Mar 13. Arch Immunol Ther Exp (Warsz). 2018. PMID: 29536116 Free PMC article. Review. - Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine.
Tomar GB, Srivastava RK, Gupta N, Barhanpurkar AP, Pote ST, Jhaveri HM, Mishra GC, Wani MR. Tomar GB, et al. Biochem Biophys Res Commun. 2010 Mar 12;393(3):377-83. doi: 10.1016/j.bbrc.2010.01.126. Epub 2010 Feb 6. Biochem Biophys Res Commun. 2010. PMID: 20138833 - Trafficking and differentiation of mesenchymal stem cells.
Liu ZJ, Zhuge Y, Velazquez OC. Liu ZJ, et al. J Cell Biochem. 2009 Apr 15;106(6):984-91. doi: 10.1002/jcb.22091. J Cell Biochem. 2009. PMID: 19229871 Review. - A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications.
Cislo-Pakuluk A, Marycz K. Cislo-Pakuluk A, et al. Stem Cell Rev Rep. 2017 Oct;13(5):598-602. doi: 10.1007/s12015-017-9750-4. Stem Cell Rev Rep. 2017. PMID: 28643176 Free PMC article. Review. - Distribution of murine adipose-derived mesenchymal stem cells in vivo following transplantation in developing mice.
Liao X, Li F, Wang X, Yanoso J, Niyibizi C. Liao X, et al. Stem Cells Dev. 2008 Apr;17(2):303-14. doi: 10.1089/scd.2007.0086. Stem Cells Dev. 2008. PMID: 18447645
Cited by
- Three-dimensional printing in orthopaedic surgery: A review of current and future applications.
Thiruchandran G, Dean O, Alim D, Crawford A, Salim O. Thiruchandran G, et al. J Orthop. 2024 Jul 20;59:22-26. doi: 10.1016/j.jor.2024.07.013. eCollection 2025 Jan. J Orthop. 2024. PMID: 39355450 - Hematopoietic and leukemic stem cells homeostasis: the role of bone marrow niche.
Khattab S, El Sorady M, El-Ghandour A, Visani G, Piccaluga PP. Khattab S, et al. Explor Target Antitumor Ther. 2024;5(5):1027-1055. doi: 10.37349/etat.2024.00262. Epub 2024 Aug 15. Explor Target Antitumor Ther. 2024. PMID: 39351440 Free PMC article. Review. - Young small extracellular vesicles rejuvenate replicative senescence by remodeling Drp1 translocation-mediated mitochondrial dynamics.
Peng Y, Zhao T, Rong S, Yang S, Teng W, Xie Y, Wang Y. Peng Y, et al. J Nanobiotechnology. 2024 Sep 5;22(1):543. doi: 10.1186/s12951-024-02818-5. J Nanobiotechnology. 2024. PMID: 39238005 Free PMC article. - Time- and cell-specific activation of BMP signaling restrains chondrocyte hypertrophy.
Gadomski SJ, Mui BWH, Gorodetsky R, Paravastu SS, Featherall J, Li L, Haffey A, Kim JC, Kuznetsov SA, Futrega K, Lazmi-Hailu A, Merling RK; NIDCD/NIDCR Genomics and Computational Biology Core,; Martin D, McCaskie AW, Robey PG. Gadomski SJ, et al. iScience. 2024 Jul 18;27(8):110537. doi: 10.1016/j.isci.2024.110537. eCollection 2024 Aug 16. iScience. 2024. PMID: 39193188 Free PMC article. - Optimization of transplantation methods using isolated mesenchymal stem/stromal cells: clinical trials of inflammatory bowel diseases as an example.
Hisamatsu D, Ikeba A, Yamato T, Mabuchi Y, Watanabe M, Akazawa C. Hisamatsu D, et al. Inflamm Regen. 2024 Aug 16;44(1):37. doi: 10.1186/s41232-024-00350-5. Inflamm Regen. 2024. PMID: 39152520 Free PMC article.
References
- Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp. 1988;136:42–60. - PubMed
- Sacchetti B, et al. Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment. Cell. 2007;131:324–336. - PubMed
- Tavassoli M, Crosby WH. Transplantation of marrow to extramedullary sites. Science. 1968;161:54–56. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK056638/DK/NIDDK NIH HHS/United States
- HL116340/HL/NHLBI NIH HHS/United States
- HL097819/HL/NHLBI NIH HHS/United States
- R01EB009663/EB/NIBIB NIH HHS/United States
- R01 HL069438/HL/NHLBI NIH HHS/United States
- HL097700/HL/NHLBI NIH HHS/United States
- DE019412/DE/NIDCR NIH HHS/United States
- HL69438/HL/NHLBI NIH HHS/United States
- Z01 DE000380-25/ImNIH/Intramural NIH HHS/United States
- DE016513/DE/NIDCR NIH HHS/United States
- DK57501/DK/NIDDK NIH HHS/United States
- R01DE018248/DE/NIDCR NIH HHS/United States
- GGP09227/TI_/Telethon/Italy
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical